iSpecimen Inc. (ISPC) Fair Value 2026

ISPC · Services-Commercial Physical & Biological Research ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

5.0 /10

32 fundamental signals · 9 models active

Value Trap Risk

WARN (51/100)

Quick Summary — As of 2026-07-13, iSpecimen Inc. (ISPC) trades at $2.34, approximately 39% above CirclFi’s Bayesian DCF fair value of $1.69. QOC: 5.0/10. Value Trap Risk: 51/100 (WARN). 9/13 models active.

Key Facts

Ticker
ISPC
Price
$2.34
Quality Score
5.0/10
Value Trap Risk
51/100
Models Active
9/13
Last Updated
Strength: CUCE Ensemble suggests +292.3% upside with 3% confidence
Risk: Value Trap score of 51 suggests caution despite apparent undervaluation

Valuation Matrix

9 Intrinsic Value Models vs. Current Price ($2.34)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
Low Conviction
 $1.69 -27.8%
CUCE Ensemble
Low Conviction
 $9.18 +292.3%
First Chicago
Medium Conviction
 $7.80 +233.1%
Dynamic NAV
Medium Conviction
 $5.82 +148.6%

Unlock the Full Matrix

Access 5 additional models including EROIC Spread, ML-RIV, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 9 Models →

Cancel anytime · No contracts · Instant access

What Is iSpecimen Inc. (ISPC) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, the weight of evidence tilts decidedly bullish for iSpecimen Inc.. Trading at $2.34 against an estimated intrinsic value of $6.11, 7 of 9 active models flag meaningful upside of +161.1% on average. The most optimistic model, Sentiment SOTP, places fair value at $13.26 (+466.5%), while ML-RIV — the most conservative — estimates $0.14 (-94.0%). This +560.5% gap reflects genuine analytical uncertainty about iSpecimen Inc.'s intrinsic worth.

What Do the Models Say About ISPC?

9 of 13 models are currently active for ISPC. Of these, 7 models suggest upside while 2 models suggest overvaluation. The Bayesian DCF estimates ISPC's intrinsic value at $1.69, implying -27.8% downside from the current price. See which stocks rank higher →

How Does ISPC Rank in Services-Commercial Physical & Biological Research?

Among 11 Services-Commercial Physical & Biological Research stocks, ISPC ranks #8 by Quality of Company score. CirclFi's QOC score of 5.0/10 evaluates 32 fundamental signals. A score of 5.0 reflects mixed fundamentals.

iSpecimen Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is ISPC a Value Trap?

CirclFi's Value Trap algorithm assigns ISPC a score of 51/100 (WARN). This is a warning signal. Additional research into recent 10-Q filings is recommended. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

9 of 13 models are active for iSpecimen Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, iSpecimen Inc. is rated at 5.0/10. This moderate-tier score shows mixed signals across our quality framework with notable weaknesses.

The gap between the most bullish and bearish model spans +560.5% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every ISPC valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across ISPC's 9 active models, average confidence is 24%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy iSpecimen Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Services-Commercial Physical & Biological Research Stocks Should You Also Analyze?

8 related Services-Commercial Physical & Biological Research stocks with 13-model coverage

MEDPMedpace Holdings, Inc.QOC 10.0IQVIQVIA Holdings, Inc.QOC 8.7CRLCharles River Laboratories InteQOC 8.5NRCNRC HealthQOC 7.3MXCTMaxCyte, Inc.QOC 7.3OABIOmniAb, Inc.QOC 6.0BIAFbioAffinity Technologies, Inc.QOC 5.6INCYIncyte CorporationQOC 4.3

Read investment analysis: MEDP · IQV · CRL · NRC · MXCT

Frequently Asked Questions About iSpecimen Inc.

What is iSpecimen Inc.'s intrinsic value in 2026?

Based on CirclFi's 13-model analysis, iSpecimen Inc. (ISPC) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $1.69. The Quality of Company score is 5.0/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is ISPC overvalued or undervalued right now?

At $2.34, 7 of 9 active models suggest ISPC may be undervalued, while 2 indicate potential overvaluation. The assessment depends on which methodology best fits iSpecimen Inc.'s business model in Services-Commercial Physical & Biological Research.

What does a Quality of Company score of 5.0 mean for ISPC?

iSpecimen Inc.'s QOC of 5.0/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on ISPC?

CirclFi analyzes ISPC with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 9 of 13 are active for this stock. Read the full methodology →

Is ISPC a value trap in 2026?

iSpecimen Inc.'s Value Trap score is 51/100 (WARN). This elevated score suggests the stock may look undervalued but faces deteriorating fundamentals — declining margins, rising debt, or shrinking revenue could make the apparent discount deceptive. Browse our ranked stock lists to compare value-trap scores across industries. Browse stocks by value-trap risk →

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 9 mathematical frameworks give you clarity on ISPC.

Unlock All 9 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access